Voyageur Pharmaceuticals (CVE:VM) Shares Up 17.6% – Here’s What Happened

Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report)’s stock price was up 17.6% during mid-day trading on Monday . The stock traded as high as C$0.20 and last traded at C$0.20. Approximately 134,500 shares were traded during mid-day trading, a decline of 48% from the average daily volume of 256,409 shares. The stock had previously closed at C$0.17.

Voyageur Pharmaceuticals Trading Up 5.9 %

The company has a quick ratio of 0.84, a current ratio of 0.10 and a debt-to-equity ratio of 4.23. The company has a market cap of C$27.27 million, a price-to-earnings ratio of -16.84 and a beta of 0.32. The business has a fifty day simple moving average of C$0.16 and a 200 day simple moving average of C$0.10.

Voyageur Pharmaceuticals Company Profile

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

See Also

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.